Characterizing cognition across the lifespan in untreated psychosis in China
Characterizing cognition across the lifespan in untreated psychosis in China
批准号:
9403816
负责人:
MATCHERI S. KESHAVAN
金额:
$60.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2020-05-31
关键词:
AddressAgeAntipsychotic AgentsAttenuatedBipolar DisorderBrainChinaClinicalClinical PsychologyCognitionCognitive deficitsCollaborationsCommunitiesCountryCross-Sectional StudiesDiagnosticEducational workshopEpidemiologyEthicsGenderGoalsGrantIncomeIndividualInterdisciplinary StudyInterventionLife Cycle StagesLocalesLongevityLongitudinal StudiesMeasuresMental Health ServicesModelingPatientsPatternPersonsPharmaceutical PreparationsPopulationProceduresProvincePsychiatric epidemiologyPsychiatryPsychotic DisordersRecording of previous eventsRecruitment ActivityResearchResearch Domain CriteriaResearch InfrastructureResearch PersonnelResearch TrainingRoleSamplingSchizoaffective DisordersSchizophreniaSeveritiesSymptomsTestingTrainingTraining ProgramsVerbal Learningage relatedcareercohortcomparison groupexecutive functionexperiencefollow-upinsightprocessing speedprogramspublic health relevanceresponsescale upsevere mental illnesstreatment programyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to take advantage of a unique opportunity to study cognition and its relation to other domains in a large untreated sample of individuals with psychosis (IWP), within an ethically appropriate context that is unlikely to continue to be available. After the onset of psychosis, studies of cognition in treated IWP suggest persisting deficits in many SCZ patients; these are present in bipolar affective psychoses to a somewhat lesser extent, indicating a continuum of severity in psychosis. To address this, we propose to study cognition among a large sample (n=500) of completely untreated IWP, assessed prior to AP treatment, within Ningxia Province who span a wide age range (21 to 65) and are community sampled. Ningxia is among the most poor and remote provinces in China, where the 686 Program has not fully penetrated but where identification of untreated cases is increasing. A community sampled comparison group of treated IWP's (n=500) (matched on locale, gender, age, and duration of illness) will also be recruited. Our goal is to illuminate the natural course of cognition and its relation to symptoms and functioning, in the absence of medication effects. We possess an unprecedented opportunity to do so within the 686 national treatment program. Our multidisciplinary research team is comprised of world-recognized experts from the fields of epidemiology, clinical psychology, and psychiatry. Building upon a history of successful collaborations, each investigator brings extensive capacity-building experience to execute this challenging project. A major goal is also to train a new cohort of investigators in Ningxia Province to increase capacity to intervene with untreated psychosis, thus serving as a model for scale-up for the 686 program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
-
批准号:10683233
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2022
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10396433
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5: Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)
-
批准号:10613507
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Longitudinal trajectories in treated and untreated schizophrenia
-
批准号:10306962
-
项目类别:
-
资助金额:$64.17万
-
财政年份:2021
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9139499
-
项目类别:
-
资助金额:$62.48万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Sleep spindles in early course schizophrenia and first-degree relatives
-
批准号:9702857
-
项目类别:
-
资助金额:$55.46万
-
财政年份:2015
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Adaptation of Cognitive Enhancement Therapy for persons at Psychosis High Risk
-
批准号:8976169
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2014
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8506547
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/6 Psychosis and Affective Research Domains and Intermediate Phenotypes (PARDIP)
-
批准号:8706965
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2013
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8453355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8644914
-
项目类别:
-
资助金额:$60.76万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8236770
-
项目类别:
-
资助金额:$67.46万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
批准号:8831006
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2012
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
CORE--CLINICAL
-
批准号:7553455
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
4/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes
-
批准号:9293368
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7668419
-
项目类别:
-
资助金额:$80.15万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7917305
-
项目类别:
-
资助金额:$77.04万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
-
批准号:7384973
-
项目类别:
-
资助金额:$80.95万
-
财政年份:2007
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
EFFECT OF QUETIAPINE ON DELTA SLEEP DEFICITS IN SCHIZOPHRENIA
-
批准号:7201198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
BRAIN CIRCUITRY AND COGNITION IN PSYCHOSIS
-
批准号:7201211
-
项目类别:
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:MATCHERI S. KESHAVAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: